These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7848339)

  • 1. Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
    Oyasu H; Yamamoto T; Sato N; Sawada T; Ozaki R; Mukai T; Ozaki T; Nishii M; Sato H; Fujiwara T
    Arzneimittelforschung; 1994 Nov; 44(11):1242-9. PubMed ID: 7848339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency.
    Yamamoto T; Koibuchi Y; Miura S; Sawada T; Ozaki R; Esumi K; Ohtsuka M
    J Urol; 1995 Dec; 154(6):2174-8. PubMed ID: 7500484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
    Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
    Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Sato A; Hasegawa T; Nishikibe M; Mitsuya M; Ohtake N; Mase T; Noguchi K
    J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle.
    Yono M; Yoshida M; Takahashi W; Inadome A; Ueda S
    BJU Int; 2000 Oct; 86(6):719-25. PubMed ID: 11069384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.
    Ohtake A; Ukai M; Hatanaka T; Kobayashi S; Ikeda K; Sato S; Miyata K; Sasamata M
    Eur J Pharmacol; 2004 May; 492(2-3):243-50. PubMed ID: 15178371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
    Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of propiverine hydrochloride (propiverine) on the muscarinic receptor binding affinity in guinea pig tissues and on salivation in conscious dogs].
    Nagao M; Kaneko S; Hirota T; Isogai M; Shimizu H
    Nihon Yakurigaku Zasshi; 1999 Mar; 113(3):157-66. PubMed ID: 10347840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of solifenacin on human isolated urinary bladder.
    Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S
    Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats.
    Sugiyama Y; Yoshida M; Masunaga K; Satoji Y; Maeda Y; Nagata T; Inadome A; Ueda S
    Int J Urol; 2008 Jan; 15(1):76-81. PubMed ID: 18184179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
    McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
    Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
    Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
    Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of propiverine hydrochloride on the spontaneous contractions of isolated guinea-pig urinary bladder strip and rhythmic urinary bladder contractions of anesthetized dog.
    Haruno A
    Arzneimittelforschung; 1992 Dec; 42(12):1459-61. PubMed ID: 1288511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
    Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
    Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G
    Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
    Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
    BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels.
    Gilani AH; Khan AU; Raoof M; Ghayur MN; Siddiqui BS; Vohra W; Begum S
    Fundam Clin Pharmacol; 2008 Feb; 22(1):87-99. PubMed ID: 18251725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.